Biotech Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs August 1, 2026
Biotech IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 31, 2026
Biotech Agios Reports Second Quarter 2026 Financial Results and Provides Business Update July 30, 2026
Biotech Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use July 30, 2026
Biotech Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 July 29, 2026